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Abstract
Background: Prevention of depression is a priority to reduce its global disease burden. Targeting specific risk factors, such as
rumination, may improve prevention. Rumination-focused Cognitive Behavioral Therapy (RFCBT) was developed to specifically
target depressive rumination.
Objective: The primary objective of this study was to test whether guided Web-based RFCBT (i-RFCBT) would prevent the
incidence of major depression relative to usual care in UK university students. The secondary objective was to test the feasibility
and estimated effect sizes of unguided i-RFCBT.
Methods: To address the primary objective, a phase III randomized controlled trial was designed and powered to compare high
risk university students (N=235), selected with elevated worry/rumination, recruited via an open access website in response to
circulars within universities and internet advertisements, randomized to receive either guided i-RFCBT (interactive Web-based
RFCBT, supported by asynchronous written Web-based support from qualified therapists) or usual care control. To address the
secondary objective, participants were also randomized to an adjunct arm of unguided (self-administered) i-RFCBT. The primary
outcome was the onset of a major depressive episode over 15 months, assessed with structured diagnostic interviews at 3
(postintervention), 6, and 15 months post randomization, conducted by telephone, blind to the condition. Secondary outcomes of
symptoms of depression and anxiety and levels of worry and rumination were self-assessed through questionnaires at baseline
and the same follow-up intervals.
Results: Participants were randomized to guided i-RFCBT (n=82), unguided i-RFCBT (n=76), or usual care (n=77). Guided
i-RFCBT reduced the risk of depression by 34% relative to usual care (hazard ratio [HR] 0.66, 95% CI 0.35 to 1.25; P=.20).
Participants with higher levels of baseline stress benefited most from the intervention (HR 0.43, 95% CI 0.21 to 0.87; P=.02).
Significant improvements in rumination, worry, and depressive symptoms were found in the short-to-medium term. Of the 6
modules, guided participants completed a mean of 3.46 modules (SD 2.25), with 46% (38/82) being compliant (completing ≥4
modules). Similar effect sizes and compliance rates were found for unguided i-RFCBT.
Conclusions: Guided i-RFCBT can reduce the onset of depression in high-risk young people reporting high levels of
worry/rumination and stress. The feasibility study argues for formally testing unguided i-RFCBT for prevention: if the observed
effect sizes are robustly replicated in a phase III trial, it has potential as a scalable prevention intervention.
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Introduction
Background
Depression is the leading cause of disease burden worldwide,
accounting for 7.5% of all years lived with disability in 2015
[1], with considerable individual, societal, and economic
consequences. Although there are effective evidence-based
acute treatments, their impact is limited because of poor access
to treatments [2], high rates of nonresponse [3], and the recurrent
nature of depression, with 50% to 80% of patients experiencing
2 or more episodes [4]. It is estimated that even with optimal
acute treatment at full coverage, only 34% of the disease burden
would be averted [5]. As a consequence, a strong case has been
made that prevention is needed to reduce the global burden of
depression [6].
Preventive interventions, largely using cognitive behavioral
therapy (CBT) approaches, can reduce symptoms of depression
and prevent the incidence of depression [7-9], with an average
reduction of 21% in incidence rates [10]. These meta-analyses
suggest that targeted interventions (selective interventions aimed
at subgroups with known risk factors and indicated interventions
aimed at those with subclinical symptoms) produce larger and
longer-lasting effects than universal interventions aimed at entire
populations. A meta-analysis [11] of 21 preventive interventions
(15 using CBT approaches) found that selective interventions
and indicated interventions had lower incidence rate ratios (IRR;
0.72 and 0.76, respectively) relative to controls than universal
interventions (IRR=0.90). Merry et al [8] also found that both
universal and targeted interventions reduced incidence relative
to no intervention in the short-to-medium term (3 to 9 months
postintervention) but only targeted interventions reduced
incidence at 12 months. Thus, targeting at-risk groups may
improve the efficacy of preventive interventions for depression
[6], in part because the base rate is higher in targeted samples,
so it is easier to detect a significant effect with smaller sample
sizes [12].
The incidence of depression rises steeply from the age of 14
years through young adulthood, with increased rates in females
(2:1, female:male) emerging at around the age of 12 years and
continuing into young adulthood [13]. The UK Adult Psychiatric
Morbidity Survey found increasing rates of common mental
health disorders (CMDs; incorporating depression and anxiety
disorders) among young women (aged 16 to 24 years), rising
from 22.2% in 2007 to 28.2% in 2014 [14], with rates in young
women almost three times those of young men (10.0%) in 2014.
As early onset is linked to greater chronicity [15] and other
negative long-term outcomes, such as poor academic and
occupational performance [1,16], prevention may be particularly
effective and impactful for this age group.
Within this age range, university students are a particularly
high-risk group, with a weighted mean prevalence for depression
of 30.6% (range 10% to 85%) across 24 studies [17] relative to
estimates of 10.8% to 22% in nonstudents of the same age range
[18,19]. This increased prevalence may be due to the specific
pressures of university and associated lifestyle changes, such
as leaving the family home for the first time, forming new
friendships, more self-directed learning, and irregular sleep
patterns [20]. Students who experience mental health difficulties
during their studies are at greater risk of poor academic
outcomes [16] and dropout [21].
Despite these challenges, students often do not seek help from
relevant services [22,23]. Alternative delivery modes, such as
Web-based interventions, offer advantages that may be attractive
to students, including availability at any time and place,
anonymity which may reduce the stigma of seeking help, and
more time to reflect on the treatment material [12,24,25]. A
recent systematic review and meta-analysis of 17 Web-based
and computer-delivered interventions for higher education
students found reductions in depression, anxiety, and stress
when compared with inactive controls [26]. However, sample
sizes were generally small, and the authors recommend further
larger-scale trials to assess the effectiveness of Web-based
interventions in university students.
One such relatively large-scale trial by Topper et al [27] tested
a guided Web-based targeted preventive intervention for 251
high school and university students aged 15 to 22 years with
high levels of self-reported worry and rumination. Participants
were randomized to face-to-face group rumination-focused
cognitive-behavioral therapy (RFCBT), guided Web-based
RFCBT (i-RFCBT), or a no-intervention control group. This
preventive intervention is based on RFCBT, previously shown
to be effective in treating residual depression [28]. There is
considerable evidence that rumination plays a causal role in the
onset and duration of major depressive episodes (MDEs) [29,30].
Within a student population, rumination predicts change in
depression over 6 months [31]. Rumination interacts with other
risk factors to both maintain depression (the combination of
rumination, low self-esteem, and stressful life events predicts
maintenance of depressive symptoms over 6 weeks [32]) and
predict the onset of depressive symptoms (engaging in
rumination in response to stress prospectively predicted an
increase in subsequent depressive symptoms [33]). These studies
suggest that specifically targeting ruminative responses to
stressful events could reduce depression.
J Med Internet Res 2019 | vol. 21 | iss. 5 | e11349 | p.2https://www.jmir.org/2019/5/e11349/
(page number not for citation purposes)
Cook et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
RFCBT specifically targets repetitive negative thought (RNT),
incorporating both rumination and worry, defined as a thinking
style that: (1) is repetitive, intrusive, and difficult to disengage
from; (2) is perceived as unproductive; and (3) captures mental
capacity [34]. RNT is a transdiagnostic process, involved in the
onset and maintenance of a range of emotional disorders
including depression and anxiety as well as physical health
issues [29,35], including in children and adolescents [36-39].
Targeting transdiagnostic risk factors has the potential to
improve the efficacy of prevention by impacting on multiple
disorders with a single intervention [27].
In the Topper et al [27] trial, both Web-based and
group-delivered RFCBT reduced symptoms of depression and
anxiety (d=0.36 to 0.72), relative to controls. Cumulative
incidence rates at the final 12-month follow-up were
significantly lower in both RFCBT intervention conditions for
depression (14.7% Web-based; 15.3% group) relative to the
usual care control condition (32.4% depression), with no
difference between i-RFCBT versus group RFCBT. In support
of the hypothesized mechanism of change, reductions in worry
and rumination were found to mediate the effects of the
interventions on prevalence of depression and Generalized
Anxiety Disorder (GAD). These findings suggest that targeting
rumination may have preventive effects for depression and are
consistent with evidence that targeted prevention can be effective
in adolescents and young adults.
Objectives
Topper et al [27] included both secondary and university
students to form a heterogeneous sample. Given the evidence
that undergraduates may form a distinct at-risk subgroup for
depression, the primary aim of this phase III efficacy trial was
to test whether these beneficial effects of guided i-RFCBT on
onset of depression relative to usual care [27] could be extended
to a selective UK high-risk undergraduate population.
We also aimed to address several key limitations of the Topper
et al [27] trial: (1) there was no diagnostic interview to assess
depression, and self-report measures were only able to estimate
point prevalence caseness and (2) as history of depression was
not assessed, participants’ previous history of depression was
not known, and therefore it was not possible to discriminate
whether the intervention prevented first onset or
relapse/recurrence of depression. To address these
methodological limitations, we included a well-validated
diagnostic interview (Structured Clinical Interview for DSM-IV
[SCID-I] [40]) to increase accuracy of the current diagnostic
status and measure retrospective incidence.
We hypothesized that in high-ruminating undergraduates, guided
i-RFCBT, relative to usual care, would significantly reduce the
onset of MDEs over the course of the 15 months post
randomization follow-up (primary outcome). Rumination has
also been found to increase the negative effect of stressful life
events on depressive symptoms in young people and students
[32,33]. This observed interaction is consistent with the evidence
that rumination contributes to depression by exacerbating
existing negative mood and negative cognitions and by
repetitively dwelling on difficulties [29,30], such as results from
stressful events. As such, a tendency to ruminate would be
expected to have less impact when things are going well and
there is less to dwell on, relative to when things are difficult.
We therefore hypothesized that i-RFCBT would be particularly
beneficial for high-ruminating undergraduates who were also
experiencing stressful life events, as this would be the group
for whom rumination would be most detrimental.
As a secondary aim, we explored the feasibility and acceptability
of an unguided version of i-RFCBT to prevent depression.
Topper et al [27] used i-RFCBT that was guided and supported
by a therapist because past evidence suggested that, at least for
acute treatment for depression, guided Web-based cognitive
behavioral therapy (i-CBT) is significantly more effective than
unguided (ie, self-help) i-CBT [41-43], and only guided i-CBT
produces similar treatment effects to face-to-face therapy in
patients with acute depressive symptoms [24]. A key rationale
for Web-based therapy is to increase the coverage, availability,
and accessibility of treatment, by potentially reaching large
numbers of people through the internet and by overcoming
hurdles such as geographical distance, poor mobility, and
scheduling appointments during standard office hours. However,
any form of guided i-CBT (including i-RFCBT) is necessarily
limited in its scalability because coverage is determined by the
number and availability of therapists. In contrast, an unguided
form of Web-based therapy has nearly limitless scalability as
there are no such constraints and, thus, even with smaller effect
sizes than guided interventions, has significant potential to
reduce the disease burden of depression [44]. Such an
intervention would be particularly beneficial for preventing
depression because effective prevention requires an intervention
to be highly scalable and able to reach very high numbers of
people. As a secondary question, we therefore explored the
feasibility and acceptability of an unguided version of i-RFCBT
in a quasi-phase II pilot arm and estimated its effect sizes to
inform a fully powered trial, with regard to incidence rates and
symptom levels (descriptives and CIs).
Methods
Trial Design
Phase III Efficacy Study
The phase III study consisted of a single (researcher) blind
parallel-group randomized controlled trial (RCT), comparing
guided i-RFCBT versus a usual care control group. For full
details, see the trial protocol paper [45] and Current Controlled
Trials ISRCTN12683436.
Quasi-Phase II Pilot Arm
To assess the feasibility of unguided i-RFCBT, a separate
adjunct arm of unguided i-RFCBT was included as a quasi-phase
II pilot arm. For efficiency, participants were randomized to
this arm within the overall trial design, but there was no direct
comparison between the unguided and guided arms. The
unguided arm was compared with the control group to estimate
the effect sizes of an unguided version of i-RFCBT for the
planning of future efficacy trials.
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Participants
Participants were university students resident in the United
Kingdom, aged 18 to 24 years, with elevated RNT, defined as
scoring above the 75th percentile on at least one measure of
worry/rumination: ≥50 on the Penn State Worry Questionnaire
(PSWQ; [46]); ≥40 on the Ruminative Response Scale (RRS;
[47]), using the same criteria as Topper et al [27]. As a
prevention study, participants were excluded if they met the
diagnostic criteria for a current (within the past month) MDE.
In addition, potential participants were excluded if they reported
any of the following: current and significant substance abuse
or dependence; current symptoms/diagnosis of psychosis or
bipolar disorder; and current psychological therapy or active
suicide risk. In line with standard practice, receipt of
antidepressant medication was not an exclusion criterion,
providing the dose had been stable for at least 1 month.
Sample Size Calculation and Recruitment
For the primary question comparing guided i-RFCBT to usual
care control, assuming a similar hazard ratio of 0.41 for the
guided i-RFCBT versus usual care control [27], 75 participants
per arm would provide 0.86 power (2-tailed 5% alpha level) to
detect this effect. For change in depressive symptoms, the
observed effect size was d=0.51 [27]. A total of 78 participants
per arm would be needed for 80% power to detect a similar
effect at the 2-tailed 5% alpha level, allowing for 20% follow-up
dropout attrition. With no previous evidence for unguided
i-RFCBT, the comparison of unguided i-RFCBT to usual care
was conducted as a feasibility study as a first step to conducting
a fully powered trial of unguided i-RFCBT. As such, no power
or sample size calculations were conducted for the unguided
arm. We aimed to recruit the same number (n=78) as the other
2 arms.
The full recruitment procedure is outlined in Cook and Watkins
[45]. Briefly, 1834 university departments in the United
Kingdom were contacted between November 14, 2013, and
December 10, 2014 (1527 contacted twice) and asked to
advertise the study. In total, 336 departments confirmed the
study was advertised either by email or as a poster. This
advertisement contained a link to an open-access screening
website. Twitter and Facebook were also used to circulate the
advertisement to young people who expressed an interest in the
following terms: stress; worry; rumination; mental health;
self-esteem; well-being; research; psychology; CBT; and online
therapy. In addition, 3 organizations working with young people
or in the field of mental health agreed to advertise the study.
A 2-step procedure identified eligible participants. In the first
step, an open-access screening website with conditional
automated feedback identified potential participants for further
screening by screening in those with elevated RNT (>75th
percentile) using shortened versions of the PSWQ (4 items,
range 4 to 20, cut-off ≥12) and RRS (5 items, range 5 to 20,
cut-off ≥10), as developed by Topper et al [48]. A conservative
cut-off of 15 on PHQ-8 [49] excluded individuals likely to be
experiencing a current MDE. Eligible participants provided
contact details as consent to be contacted for further telephone
screening.
In the second step, a telephone interview consisted of brief
screening questions for alcohol and drug use, symptoms of
bipolar disorder and psychosis (Psychosis Screening
Questionnaire [PSQ]; [50]), assessment of any relevant past or
current treatments, and the SCID-I [40] sections on current and
past depressive episodes, dysthymia, and any relevant anxiety
disorders and eating disorders. As the primary objective was to
investigate the prevention of depression, diagnoses of anxiety
disorders and eating disorders were recorded but participants
meeting the criteria for any of these disorders were not excluded
from the study. The consent to interview was obtained verbally
and included providing their general practitioner’s (GP) contact
details so that appropriate clinical support could be obtained in
the event of disclosure of suicidal risk. The interview was
audio-recorded, with consent, so that the diagnostic status could
be independently checked. The same researcher conducted the
baseline and follow-up telephone interview assessments,
ensuring continuity of contact between the research team and
participants. A total of 254 participants were eligible, of whom
235 returned written informed consent and were randomized to
guided i-RFCBT (n=82), unguided i-RFCBT (n=76), or usual
care control (n=77). The Consolidated Standards of Reporting
Trials diagram (Figure 1) indicates the numbers excluded at
baseline for each of the exclusion criteria.
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Figure 1. Consolidated Standards of Reporting Trials flowchart. MDE: major depressive episode; PHQ: Patient Health Questionnaire; RNT: repetitive
negative thought; i-RFCBT: Web-based rumination-focused cognitive behavioral therapy.
Interventions
Guided Web-Based Rumination-Focused Cognitive
Behavioral Therapy
The guided intervention was an English version of i-RFCBT
(called MindReSolve), translated and adapted from the version
used by Topper et al [27] to include case examples relevant to
university students (see Multimedia Appendix 1). RFCBT differs
from standard CBT by seeking to change the process of thinking
rather than the content of individual thoughts [51]. RFCBT [52]
was developed from theoretical models and experimental
findings indicating distinct types of repetitive thought (RT) with
different consequences [29]: unconstructive RT involves an
abstract, evaluative processing mode focused on the meaning
and evaluation of events and difficulties, leading to a range of
negative consequences such as poorer problem-solving and
greater emotional reactivity, relative to constructive RT, which
involves concrete, specific, and action-oriented processing [53].
RFCBT therefore aims to shift participants from an abstract and
evaluative style to a concrete, specific, and action-oriented style
[29], consistent with evidence that concreteness training reduces
depression [54].
RNT is also theoretically conceptualized as a mental habit acting
as a form of avoidance and maintained by negative
reinforcement [55]. RFCBT therefore involves
counterconditioning the avoidant ruminative response with more
helpful coping strategies and approach behaviors [52]. In
practice, this involves the functional analysis of rumination to
help users spot triggers for rumination, to distinguish between
helpful and unhelpful RT, and to counter condition unhelpful
RT with more functional responses through the formulation of
contingency If-Then plans [52].
The internet treatment was delivered on the internet platform
and software owned, programmed, and hosted by Minddistrict
[56], accessed by a research licence purchased from Minddistrict
by the research team. The specific content of the i-RFCBT
intervention was developed and entered into the platform using
its content management system by the research team led by
Edward Watkins, using the same key intervention principles
and techniques as face-to-face RFCBT as described by Watkins
[52], adapted for the internet. i-RFCBT contains the same key
components as face-to-face RFCBT [52], split into 6 1-hour
modules, each in turn split into 3 or 4 sessions consisting of a
single Web page, with 1 to 2 weeks recommended per module
for practice of the techniques. The content includes
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psychoeducation, mood diaries, experiential audio exercises,
pictures, and video vignettes of university students talking about
their own experiences of the intervention. Modules follow the
same basic structure: reflection on the previous module;
introduction of a new technique; experiential in-session
exercises; and plans for implementation. The specific
behavior-change techniques are drawn from the following
groups in the Behavior Change Technique (BCT) Taxonomy
(v1) [57]: goals and planning (goal setting, action planning,
review behavior, and behavioral contract), feedback and
monitoring (self-monitoring of behavior and outcomes), shaping
knowledge (information about antecedents), natural
consequences (information about social and environmental
consequences and monitoring of emotional consequences),
associations (prompts/cues and associative learning), repetition
and substitution (behavioral practice/rehearsal, behavior
substitution, and habit formation), antecedents (restructuring
the physical and social environment and avoiding/reducing cues
for the behavior), and self-belief (mental rehearsal of successful
performance, focus on past success, and self-talk). The key
strategies include coaching participants to spot warning signs
for rumination and worry, and then to make If-Then plans in
which an alternative strategy is repeatedly practised in response
to the warning signs. These strategies include being more active,
slowing things down, breaking tasks down, opposite action,
relaxation, concrete thinking, becoming absorbed,
self-compassion, and assertiveness.
The intervention was accessed individually, for free, on a secure,
password-protected website. Access was granted using an email
link, inviting the participant to set up a personal account and
password. The intervention was supported by qualified clinicians
who had received additional specific training in RFCBT. This
support consisted of asynchronous written feedback provided
by the clinician at the end of each module. Feedback served to
highlight positive steps and identified areas to focus on in the
following module. Feedback was constrained by template
responses for each module, faithful to the RFCBT model, which
could be adapted to individual participants’ responses. All the
content and module order were identical across participants,
ensuring treatment fidelity. Each module was self-paced, but
the participants were advised to spend 1 to 2 weeks on each and
could only access the next module once feedback from the
clinician was received, typically within 2 working days.
Clinicians monitored log-ons and sent personalized reminder
emails if there was no log-on for over a week. The platform
also sent an automatic weekly reminder if the platform had not
been accessed for a week. Suicidal risk was also monitored
using a well-established departmental protocol to determine the
level of risk and seek clinical support as appropriate.
Therapists were provided with regular supervision with the
developer of RFCBT (EW) to further encourage treatment
fidelity. All (100%) feedback reviewed by EW were faithful to
the intervention model (over 10% of therapist feedback
sampled—a minimum of the 3 initial feedback for each therapist,
plus a random subset of later feedback).
Unguided Web-Based Rumination-Focused Cognitive
Behavioral Therapy
The content of unguided i-RFCBT was almost identical to
guided i-RFCBT with minor adaptations for self-help to include
some automatic Web-based conditional feedback addressing
common challenges with the exercises. Access was granted via
an email link to set up a personal account and password.
Participants could then access all modules without restriction
but were advised to spend 1 to 2 weeks on each to allow time
for practice. Responses were not monitored except for weekly
checks of questionnaires to identify and follow up suicidal risk
as necessary.
Usual Care Control Condition
Participants in the usual care control condition were permitted
to access any other treatments during the study, as necessary.
They were also offered access to unguided i-RFCBT at the end
of the follow-up period.
Measures
All measures were completed at baseline, 3 months, 6 months,
and 15 months unless otherwise stated. Diagnostic interviews
for the primary outcome were conducted by telephone, with the
option to complete self-report questionnaire measures for
secondary outcomes during the telephone interview or request
for them to be returned by email/post.
TheSCID-I [40] is a semistructured diagnostic interview for
Axis I DSM-IV diagnoses. The SCID-I was used to assess MDE
(current and past), anxiety disorders, and eating disorders. The
interrater reliability for Axis I diagnoses is fair to excellent,
with a mean Kappa of 0.71 [58]. In the event of disclosure of
suicidal risk during the diagnostic interview, the researcher
followed a well-established departmental protocol to assess risk
and obtain clinical support as needed.
The Episodic Life Event Interview, part of the University of
California Los Angeles Life Stress Interview [59], assessed the
number and impact of stressful events since the previous
assessment (for the previous 3 months at baseline). Participants
provided a list of events experienced and a subjective rating of
stress experienced as a result of the worst event. The original
scale ranges from 1 none to 5 severe. Participants scored 0 if
no events were experienced. To aid analysis and interpretation,
stress was recoded to collapse 0 no event and 1 event
experienced but no stress into a single no stress category. The
recoded stress scale therefore ranges from 0 no stress to 4 severe
stress.
The PSWQ [46] is a 16-item self-report questionnaire assessing
frequency, intensity, and automaticity of worry (eg, “My worries
overwhelm me” and “I know I shouldn’t worry about things,
but I just can’t help it”). It is scored from 1 (not at all typical of
me) to 5 (very typical of me), with higher scores indicating
higher levels of worry. The internal consistency is high with
good test-retest reliability [46]. The PSWQ has also been shown
to have good predictive validity for symptoms of anxiety and
depression [60].
The RRS [47] is a self-report measure of frequency of ruminative
responses to depressed mood, with items relating to the self (eg,
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“Think about all your shortcomings, failings, faults and
mistakes”), one’s symptoms (eg, “Think about how hard it is
to concentrate”) and possible causes and consequences of one’s
mood (eg, “Go away by yourself and think about why you feel
this way”). Items are scored from 1 (almost never) to 4 (almost
always). Higher scores indicate higher levels of rumination.
The RRS has good internal consistency, moderate test-retest
reliability, acceptable convergent validity, and good predictive
validity [47,61,62].
The Patient Health Questionnaire (PHQ-9; [63]) is a 9-symptom
measure of depressive symptoms. Scores range from 0 to 27,
with higher scores indicating greater severity. The PHQ-9 is a
reliable and valid measure of severity of depressive symptoms
[63].
The GAD Screener (GAD-7; [64]) is a standardized self-report
measure of symptoms of anxiety. Scores range from 0 to 21,
and higher scores indicate more severe symptoms. Spitzer et al
[64] demonstrated good validity and reliability of the GAD-7.
Demographics and Treatment
At baseline, participants were asked if they had any family
history of depression (including whom and how recently) and
whether they had experienced any physical, sexual, or emotional
abuse before the age of 16 years (yes/no questions with no
further details requested). Participants were asked to report
whether they had received any mental health treatments
(medication, therapies, and use of self-help materials) before
or during the trial. Timing, duration, and dosage (for medication)
were recorded.
Randomization, Allocation Concealment, and Blinding
Independent computer-generated block randomization (block
size of 3), stratified by sex (male vs female) and a history of
depression (presence or absence of past depressive episodes),
was used to allocate participants to the guided i-RFCBT,
unguided i-RFCBT, or usual care control in a 1:1:1 ratio.
Varying block sizes were not used as the 2 levels of stratification
ensured it would be difficult for the researcher to anticipate or
determine allocation. A third party not involved in assessing or
treating the participants implemented the random allocation
sequence and informed the therapist of the condition for each
participant. The researcher responsible for recruitment and
screening was blind to allocation and unable to influence the
order of consents. As a single blind trial, the researcher
conducting outcome assessments was blind to allocation. The
researcher was not involved with any element of treatment
delivery. To preserve researcher blinding, participants were
notified of their treatment allocation by a trial therapist. Owing
to the nature of the intervention, participants and therapists
could not be blinded.
Statistical Analysis for the Phase III Efficacy Trial
Data cleaning followed the protocol set out by Tabachnick and
Fidell [65]. Unplanned missing data were handled via multiple
imputation (MI). A sensitivity analysis, assuming a variety of
MI models (Missing at Random and Missing Not at Random),
verified the likely impact of missing data. Auxiliary variables
were used to improve the estimation of missing data. Primary
analyses were conducted on the intention-to-treat (ITT) sample.
Additional analyses assessed the effect of compliance using the
Complier Average Causal Effect (CACE) analysis [66]. The
CACE analysis provides an unbiased estimate of the benefits
of compliance by comparing the compliers in the intervention
group to a comparable subgroup of the control group who would
have complied had they been offered the intervention.
Compliance was defined in the protocol as fully completing at
least 4 of 6 modules, that is, accessing all of the sections in each
of those modules [45]. Analyses were carried out using statistical
software, Stata (StataCorp; version 15.1 [67]).
As a prevention study, the primary outcome was the occurrence
and time to onset of any depressive episode by 15-month
follow-up. To investigate this, Cox proportional hazard models
were fitted to the depression event data, with the diagnosis of
an episode of major depression at any point during the follow-up
period as the outcome and time to onset measured in weeks
from the randomization date. Participants were censored upon
measurement dropout or end of study. The Cox proportional
hazard model was initially adjusted for both stratification
variables: past depression and gender, as they have previously
been found to influence likelihood of depression. In addition,
as baseline stress was expected to increase the risk of depression
and Topper et al [27] controlled for stressful life events, severity
of baseline stress was included in the model. To examine the
hypothesis that i-RFCBT would be especially beneficial in high
ruminators experiencing high stress, we further tested the
potential interactions between intervention condition and
baseline stress, and intervention condition and history of
depression within the Cox proportional hazard analysis.
Secondary outcomes of symptom severity and levels of
rumination/worry were examined using mixed model analyses
of covariance (ANCOVAs): between group (ITT/CACE) and
repeated measures (3- to 15-month follow-ups), controlling for
baseline symptom levels.
Feasibility and Acceptability (Quasi-Phase II Pilot
Arm)
Feasibility of data collection procedures was assessed by
measuring the missing items on clinical outcome measures,
number and timing of dropouts, and whether these varied across
arms. The acceptability of the intervention was assessed using
a behavioral index, measuring the number of Web-based
modules completed.
Ethical Approval and Informed Consent
Ethical and professional guidelines were followed at all times,
in line with Good Clinical Practice guidelines. Ethical approval
was obtained from the Ethics Committee of the School of
Psychology, University of Exeter (Ref: 2012/554). Participants
returned written informed consent including permission to
contact their GP if significant risk was disclosed (see Multimedia
Appendix 2).
Results
Demographics
For brevity, baseline demographics for the 3 arms are included
in Table 1. As noted earlier, the primary comparison is guided
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i-RFCBT versus usual care control, with a separate analysis of
the feasibility and acceptability of the adjunct unguided
i-RFCBT arm.
Survival Analysis: Guided Web-Based
Rumination-Focused Cognitive Behavioral Therapy
Versus Usual Care Control
A total of 27 participants in the primary comparison of guided
i-RFCBT versus the control completed no follow-ups, and no
minimum survival time could be estimated, so the ITT survival
analyses were conducted on n=132 (guided n=63 and control
n=69). Participants with a family history of depression were
more likely to be lost to follow-up than those without: χ21=3.89;
P=.049. No other baseline variables were linked to loss to
follow-up: all t values on continuous measures were <1.70; all
chi-square test values on categorical variables were <1.74; all
P values were >.09.
There was no overall difference in incidence of depression
(P=.64): 29% (n=18) of participants receiving guided i-RFCBT
and 33% (n=23) of participants receiving usual care experienced
an MDE during the follow-up period. A Cox proportional hazard
model was conducted, including past depression, gender, and
baseline stress as potential predictors of incidence of depression.
As the majority (83%) of participants were female and there
was no significant effect of gender in predicting depression,
this variable was removed from the model, such that the final
model controlled for past depression and baseline stress. As
expected, history of depression significantly increased risk, with
participants with a history of depression over two and a half
times more likely to experience an MDE than participants
without: hazard ratio (HR) 2.62, 95% CI 1.37 to 5.01; P=.004.
Baseline stress marginally increased the risk of MDEs: HR 1.40,
95% CI 0.99 to 1.99; P=.06. When controlling for both past
depression and baseline stress, there was a 34% reduced risk of
depression in the guided i-RFCBT condition relative to usual
care, although this difference was not significant: HR 0.66, 95%
CI 0.35 to 1.25; P=.20 (see Figure 2).
For Cox proportional hazard models including the interactions
between intervention condition and baseline stress, and
intervention condition and history of depression, there was no
differential effect of intervention between first onset (ie, no
history of depression) or relapse/recurrence (ie, past history of
depression) for incidence of major depression, and this
interaction was removed from the final model (HR 0.54, 95%
CI 0.15 to 1.94; P=.34; guided i-RFCBT: 38.9% first onset;
61.1% relapse vs usual care: 36.4% first onset; 63.6% relapse).
Both the effects of past depression (HR 2.52, 95% CI 1.32 to
4.81; P=.005) and baseline stress (HR 1.99, 95% CI 1.22 to
3.24; P=.006) remained significant. As hypothesized, there was
a significant interaction of the intervention condition by baseline
stress (HR 0.43, 95% CI 0.21 to 0.87; P=.02), indicating a
greater benefit of guided i-RFCBT relative to usual care (risk
of MDEs decreased by 57%) for undergraduates with higher
baseline stress.
Table 1. Baseline characteristics of usual care, guided Web-based rumination-focused cognitive behavioral therapy (i-RFCBT), and unguided i-RFCBT
intention-to-treat samples.
Unguided i-RFCBT (n=76)Guided i-RFCBTa (n=82)Usual care (n=77)Baseline characteristics
64 (84)68 (83)64 (83)Sex (female), n (%)
20.53 (1.30)20.43 (1.65)20.27 (1.55)Age (years), mean (SD)
67 (88)77 (94)70 (91)Ethnicity (white), n (%)
64 (84)75 (91)71 (92)English mother tongue, n (%)
29 (38)34 (41)29 (38)Previous major depressive episode (yes), n (%)
31 (41)38 (46)38 (49)Received previous mental health treatment (yes), n (%)
33 (43)42 (51)39 (51)Family history of depression (yes), n (%)
29 (38)34 (41)34 (44)Parent with history of depression (yes), n (%)
5 (7)5 (6)7 (9)Reported history of sexual abuse (yes), n (%)
7 (9)1 (1)7 (9)Reported history of physical abuse (yes), n (%)
11 (14)10 (12)17 (22)Reported history of emotional abuse (yes), n (%)
5.4 (3.6)5.6 (3.2)5.6 (4.1)Patient Health Questionnaire-9, mean (SD)
7.1(4.0)7.3 (4.2)6.6 (4.3)Generalized Anxiety Disorder Screener-7, mean (SD)
60.3 (10.5)62.0 (9.5)61.9 (9.0)Penn State Worry Questionnaire, mean (SD)
47.2 (10.7)49.8 (10.6)47.9 (11.1)Ruminative Response Scale, mean (SD)
3.4 (1.8)3.8 (2.4)3.6 (2.3)Stressful events in the past 3 months, mean (SD)
2.53 (0.92)2.57 (0.96)2.20 (1.11)Subjective rating of worst event, mean (SD)
ai-RFCBT: Web-based rumination-focused cognitive behavioral therapy.
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Figure 2. Survival curves for guided Web-based rumination-focused cognitive behavioral therapy (i-RFCBT) and usual care controls, adjusted for past
depression and baseline stress.
Plotting the interaction between the intervention group and
baseline stress (see Figure 3) suggests that at higher levels of
stress, guided i-RFCBT markedly reduces the risk of a
depressive episode relative to usual care, with this effect
reversing at low levels of stress (albeit in a small number of
participants, only 13.1% scoring either 0 or 1).
As further sensitivity analyses, to investigate the effect of
compliance on outcomes, we conducted a CACE analysis, using
the Loeys and Goetghebur [66] method, which only allows for
inclusion of the randomization variable in the model, and using
regression-based adjustments to include past depression and
baseline stress, which compares compliers in the intervention
group to all other participants [68]. The mean completion for
guided i-RFCBT was 3.46 (SD 2.25) for the full ITT sample
(n=159), with 46% (38/82) being compliant by completing at
least 4 of the 6 modules. The rates of compliance were higher
among those with follow-up outcome data (n=132) as used for
the CACE analysis at 60% (38/63). The results of the CACE
analyses (see Multimedia Appendix 3) were equivalent to the
ITT analysis. We therefore have only reported the primary ITT
analysis.
J Med Internet Res 2019 | vol. 21 | iss. 5 | e11349 | p.9https://www.jmir.org/2019/5/e11349/
(page number not for citation purposes)
Cook et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
Figure 3. Survival curves for guided Web-based rumination-focused cognitive behavioral therapy (i-RFCBT), unguided i-RFCBT, and usual care
controls at each level of baseline stress.
Secondary Analyses on Patient Health Questionnaire,
Generalized Anxiety Disorder, Ruminative Response
Scale, and Penn State Worry Questionnaire
Baseline adjusted ANCOVAs were conducted for each of the
symptom measures, at each of the 3 follow-ups. Estimated
means, between-group differences, and CIs are displayed in
Table 2 for the case completers and following MIs (50
imputations). For the complete cases, at 3 months, rumination
scores were significantly lower for guided i-RFCBT relative to
usual care; at 6 months, both worry and depression scores were
significantly lower for guided i-RFCBT relative to usual care,
and there was no evidence of significant between-group
differences at 15 months. Similar patterns were found when
using MI to account for differing levels of missing data across
the follow-ups.
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Table 2. Baseline adjusted symptom measures at 3, 6, and 15 months: guided Web-based rumination-focused cognitive behavioral therapy versus usual
care controls.
Estimated between-group
difference after multiple
imputations, multiple im-
putation difference (95%
CI)
Between-group difference,
difference (95% CI)
Usual care, mean (95% CI)Guided Web-based rumination-
focused cognitive behavioral
therapy, mean (95% CI)
Timepoint and measure
Follow-up 1 (3 months; n=114)
−0.55b (−2.05 to 0.96)−0.65b (−2.02 to 0.72)5.40 (4.48 to 6.33)4.75 (3.74 to 5.76)PHQ-9a
−0.53b (−2.14 to 1.09)−0.69b (−2.15 to 0.78)6.27 (5.28 to 7.25)5.58 (4.51 to 6.66)GAD-7c
−0.75b (−4.35 to 2.86)−1.18b (−4.46 to 2.11)58.45 (56.23 to 60.67)57.27 (54.85 to 59.69)PSWQd
−3.69b (−8.01 to 0.63)−3.87f (−7.53 to −0.21)48.21 (45.73 to 50.68)44.34 (41.66 to 47.02)RRSe
Follow-up 2 (6 months; n=105)
−1.97f (−3.87 to −.063)−1.82f (−3.46 to −0.18)5.52 (4.42 to 6.62)3.70 (2.48 to 4.92)PHQ-9
−1.15b (−3.16 to 0.85)−1.34b (−3.05 to 0.38)6.06 (4.91 to 7.20)4.72 (3.44 to 5.99)GAD-7
−2.71b (−6.68 to 1.25)−3.58f (−7.14 to −0.02)58.41 (56.03 to 60.79)54.83 (52.19 to 57.48)PSWQ
−3.98b (−9.48 to 1.52)−4.60b (−9.47 to 0.26)46.35 (43.12 to 49.58)41.74 (38.15 to 45.34)RRS
Follow-up 3 (15 months; n=108)
−0.38b (−2.30 to 1.55)−0.35b (−2.00 to 1.30)4.82 (3.73 to 5.91)4.47 (3.23 to 5.71)PHQ-9
−1.10b (−2.10 to 0.80)−1.31b (−2.99 to 0.38)5.73 (4.62 to 6.83)4.42 (3.16 to 5.68)GAD-7
−1.74b (−6.53 to 3.06)−3.30b (−7.43 to 0.82)58.11 (55.39 to 60.84)54.81 (51.71 to 57.91)PSWQ
1.16b (−3.99 to 6.31)1.50b (−3.28 to 6.28)44.65 (41.53 to 47.78)46.15 (42.59 to 49.72)RRS
aPHQ-9: Patient Health Questionnaire.
bNot significant.
cGAD-7: Generalized Anxiety Disorder Screener.
dPSWQ: Penn State Worry Questionnaire.
en=115 for Ruminative Response Scale (RRS) at 3 months owing to one partially completed questionnaire set.
fP<.05.
Retention, Acceptability and Effect Sizes of Unguided
Web-Based Rumination-Focused Cognitive Behavioral
Therapy
A total of 19 (25%) unguided participants did not complete any
follow-up assessments. Participants were significantly more
likely to be lost to follow-up in unguided i-RFCBT than in usual
care: χ21=4.53; P=.03.
Owing to the exploratory nature of the unguided version of
i-RFCBT, no formal CACE analysis of compliance was
undertaken for the unguided intervention. In the full ITT sample,
unguided participants completed an average of 2.66 modules
(SD 2.35). The rates of compliance (38% unguided) were not
significantly different from guided i-RFCBT (χ21=1.08; P=.30).
For the unguided intervention, participants logged in an average
of 6.25 times (SD 5.21) and accessed the intervention over an
average period of 114.92 days (SD 105.51). The
median (interquartile range) was 87 days (22-173). Guided
participants logged in an average of 7.97 times (SD 5.65) and
accessed the intervention over an average period of 110.13 days
(SD 108.44). The median (interquartile range) was 67 days
(38-156).
Estimates of Hazard Ratios for Unguided Web-Based
Rumination-Focused Cognitive Behavioral Therapy
Versus Usual Care
No formal significance analyses were undertaken, but hazard
ratios and CIs were estimated relative to usual care. Using a
Cox proportional hazard model including past depression and
baseline stress, unguided i-RFCBT showed a 36% reduced risk
of developing a depressive episode relative to controls: HR 0.64,
95% CI 0.33 to 1.24. A similar interaction between the
intervention and baseline stress was found as for guided
i-RFCBT (HR 0.48, 95% CI 0.23 to 1.00), such that unguided
i-RFCBT had larger effect sizes for undergraduates with
moderate-to-severe levels of baseline stress (see Figure 3).
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Table 3. Baseline adjusted symptom measures at 3, 6, and 15 months: unguided Web-based rumination-focused cognitive behavioral therapy versus
usual care controls.
Estimated between-group
difference after multiple
imputations, multiple im-
putation difference (95%
CI)
Between-group difference,
difference (95% CI)
Usual care, mean (95% CI)Unguided Web-based rumination-
focused cognitive behavioral ther-
apy, mean (95% CI)
Timepoint and measure
Follow-up 1 (3 months; n=116)
−1.18 (−2.65 to 0.28)−1.20 (−2.49 to 0.10)5.21 (4.33 to 6.10)4.02 (3.07 to 4.96)PHQ-9a
−1.06 (−2.60 to 0.49)−1.04 (−2.47 to 0.39)5.98 (5.01 to 6.96)4.94 (3.90 to 5.99)GAD-7b
−1.35 (−4.87 to 2.17)−1.84 (−5.28 to 1.61)57.60 (55.26 to 59.95)55.77 (53.26 to 58.28)PSWQc
−2.42 (−6.19 to 1.34)−2.54 (−6.08 to 1.01)47.01 (44.60 to 49.42)44.47 (41.89 to 47.06)RRSd
Follow-up 2 (6 months; n=104)
−1.04 (−2.89 to −0.81)−0.97 (−2.56 to 0.61)5.35 (4.30 to 6.40)4.38 (3.20 to 5.56)PHQ-9
−2.09 (−3.92 to −0.28)−1.73 (−3.38 to −0.07)5.93 (4.83 to 7.03)4.20 (2.96 to 5.44)GAD-7
−3.35 (−7.36 to 0.67)−3.55 (−7.46 to 0.36)58.06 (55.47 to 60.65)54.51 (51.60 to 57.42)PSWQ
−4.12 (−8.94 to 0.69)−3.93 (−8.22 to 0.37)45.20 (42.35 to 48.04)41.27 (38.07 to 44.47)RRS
Follow-up 3 (15 months; n=107)
−0.92 (−2.61 to 0.77)−0.49 (−2.08 to 1.11)4.69 (3.64 to 5.73)4.20 (3.00 to 5.40)PHQ-9
−1.36 (−3.23 to 0.52)−1.03 (−2.63 to 0.58)5.52 (4.46 to 6.57)4.49 (3.28 to 5.70)GAD-7
−4.34 (−8.57 to −0.09)−3.78 (−7.79 to 0.24)57.56 (54.93 to 60.19)53.78 (50.75 to 56.81)PSWQ
−2.61 (−7.93 to 2.71)−1.78 (−6.40 to 2.83)43.85 (40.84 to 46.86)42.07 (38.59 to 45.54)RRS
aPHQ-9: Patient Health Questionnaire.
bGAD-7: Generalized Anxiety Disorder Screener.
cPSWQ: Penn State Worry Questionnaire.
dRRS: Ruminative Response Scale.
Between-group differences for unguided i-RFCBT versus usual
care were estimated with baseline adjusted ANCOVAs for both
case completers and using multiple imputations (50 imputations).
Estimated means and CIs are displayed in Table 3. Owing to
the exploratory nature of this comparison, significance testing
was not conducted. Patterns of change and CIs indicate similar
symptom changes to those found in the guided i-RFCBT versus
usual care control ANCOVAs.
Discussion
Principal Findings and Comparison With Previous
Work
The main aim was to test if guided i-RFCBT could be effective
in preventing depression in undergraduate students in the United
Kingdom over 1-year follow-up. When controlling for both past
depression and baseline stress, guided i-RFCBT reduced the
risk of experiencing an MDE by 34% relative to usual care.
Although this effect size was not significant and smaller than
that found by Topper et al [27], it is consistent with the wider
prevention literature, which reports an average reduction in
incidence of 21% [10] and a 28% (IRR=.72) reduction in
incidence relative to controls for selective, predominantly CBT,
interventions [11]. It may be that this study was underpowered
to detect a main preventive effect of i-RFCBT as it used a larger
effect size estimate derived from Topper et al [27].
As hypothesized, guided i-RFCBT was significant at preventing
the onset of MDEs in high-risk undergraduates relative to usual
care when they experienced moderate or above levels of baseline
stress, with a hazard ratio of 0.43 when moderated by baseline
stress. This is consistent with theoretical models of rumination
and the RFCBT treatment approach. The tendency to ruminate
about difficulties or low mood is more likely to increase the
risk for depression in the context of stressful events, which
activates that habitual tendency and provides subject matter to
ruminate about. Even someone with a habitual tendency to
ruminate is less likely to have frequent rumination in the absence
of any difficulties. Furthermore, one key mechanism by which
rumination is proposed to increase vulnerability to depression
is by exacerbating and prolonging negative affect and distress
[29,30]: rumination does not have deleterious effects in the
absence of negative mood, and it is thus the confluence of
stressful events that lower mood and the tendency to ruminate
that particularly confer the risk for depression [32]. This pattern
of results suggests a partial replication of Topper et al [27], by
indicating that guided i-RFCBT may be a helpful preventive
intervention for university students with high levels of
rumination and worry, who also experience at least moderate
levels of stress.
We note that the observed interaction between i-RFCBT and
baseline stress could also be interpreted as indicating that
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RFCBT is unhelpful compared with usual care, for users who
are experiencing little to no current stress. However, given the
small number of participants who reported low levels of baseline
stress, this reversal is based on low power and needs to be
treated with caution.
The findings on the symptom measures suggest that guided
i-RFCBT was effective in the short-to-medium term, by reducing
rumination, worry, and symptoms of depression at 3 and 6
months relative to usual care, but that these improvements were
not sustained over the longer term. Watkins and
Nolen-Hoeksema [55] hypothesized that rumination could be
conceptualized as a learnt habit, triggered by particular cues
such as low mood. Within this analysis, successful long-term
reduction of the ruminative habit requires extensive repetition
and rehearsal of alternative more adaptive responses to the
triggers for rumination. It may be that i-RFCBT was too brief
or that participants did not practise enough to produce long-term
change in the ruminative habit. It may also be that further
engagement and booster sessions some months after the initial
intervention phase would enhance the longer-term effects of
the intervention [69]. These could take the form of explicit
reminders to practice techniques (flashcards and text/email
reminders; [70]) or increasing the generalizability of the new,
more helpful techniques across a broader range of contexts [70].
One possible reason for the difference in findings between this
study and Topper et al [27] is the means of assessing onset of
depression: Reducing Stress and Preventing Depression
(RESPOND) used structured clinical interviews, whereas Topper
et al [27] used cut-offs on self-report questionnaires, which may
overestimate incidence. Another potential explanation is the
different samples. Although their sample included university
students, the average age was 17.5 years, compared to 20.4
years in RESPOND. Cases of depression begin to rise steeply
from the age of 14 [13], so it may be that the developmental
risks during mid to late adolescence differ from those in
university students and either that i-RFCBT was more
efficacious in younger participants or the base rate was higher
in the younger sample, increasing the power of the trial.
Compliance rates and the pattern of findings and preliminary
effect sizes and CIs for unguided i-RFCBT were similar to those
for guided i-RFCBT. These findings are in contrast to the
literature on Web-based acute treatment for depression, which
generally demonstrates larger effect sizes for guided
interventions relative to unguided [41-43]. This benefit of
therapist guidance has also previously been found for indicated
preventive interventions in university students [71]. As a
preliminary finding from a feasibility pilot, further large-scale
trials are needed to confirm whether this potential equivalence
between unguided and guided i-RFCBT is robust. We speculate
that only selecting high-ruminating participants for the trial
meant that i-RFCBT was highly relevant and engaging to
participants, thus ameliorating the relative benefits of guidance
on treatment motivation and completion.
Given the need for widespread dissemination of preventive
interventions, an efficacious unguided intervention would be
valuable, even if it had somewhat reduced effect sizes relative
to the guided version, because it would not be constrained by
therapist numbers or availability unlike a guided treatment and
could be enormously scaled up to increase accessibility [44].
In addition, unguided interventions may benefit a previously
unreached population as many university students do not seek
professional help for mental health difficulties [22,23] and could
therefore be more attracted to self-help interventions. In support
of this, an unguided preventive intervention for students with
elevated distress ratings reduced depressive symptoms relative
to usual care at 2 months follow-up [72], with two-thirds of the
trial completers reporting an unmet need (needing help but not
seeking it) in the previous year. As i-RFCBT targets worry and
rumination, rather than focusing on depression, this may further
attract those who prefer self-help to manage their symptoms as
worry is a common experience without the perceived stigma of
mental illness [27]. These initial findings on the acceptability
and effect sizes of the unguided version provide some promise
in terms of potential benefits and suggests the value of further
studies to formally test unguided i-RFCBT as a preventive
intervention.
Despite the need for larger-scale trials to test the robustness of
these findings, several strengths of RESPOND are identified.
First, the RESPOND trial addressed some of the methodological
limitations of the Topper et al [27] trial by including diagnostic
interviewing. This allowed for retrospective diagnoses, capturing
any episodes occurring between follow-up interviews, as well
as baseline history of depression to assess the effect of previous
history on risk of a further MDE.
The use of Web-based and telephone-based measures allowed
for recruitment throughout the United Kingdom, with
participants from a wide range of university departments and
geographical locations, increasing the generalizability of the
findings within this demographic. The target sample size was
achieved through this recruitment strategy and this would
therefore be a suitable approach for a larger scale trial of
i-RFCBT.
Limitations
There were several limitations to the study. First, the sample
was disproportionately female, limiting the generalizability of
the findings. However, females consistently report higher levels
of rumination [73] and higher levels of depression, so a trial
selecting on this basis will necessarily attract more female
participants.
Second, despite a successful recruitment strategy, there was a
considerable proportion of missing data at follow-up, particularly
in the intervention conditions (albeit in the context of planning
the sample size for 20% drop-out attrition). In addition,
follow-up assessments were sometimes incomplete as
participants did not always return the questionnaires after the
follow-up interview, despite reminders being sent. Future trials
should therefore further emphasize to participants the importance
of follow-up data during the baseline assessment and ensure all
measures are completed during the interview. Finally, common
to many electronic mental health trials, the participants were
not blind to the treatment condition, and, as such, the results
could have been influenced by response bias and expectancy
effects.
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Conclusions
Despite these limitations, taken together, the findings from the
Topper et al [27] trial and from this RESPOND trial suggest
that i-RFCBT is an effective and acceptable intervention for
preventing depression in adolescents and undergraduates
experiencing high levels of rumination and worry. This
demonstrates the value in targeting a preventive intervention at
identified risk factors. This intervention may be particularly
effective in individuals experiencing high levels of stress. The
initial findings relating to unguided i-RFCBT suggest this may
be efficacious in preventing depression, which, if shown to be
robust in a fully powered trial, would have significant
implications for the scalability of i-RFCBT.
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